| James R Swartley, MD | |
|
222 N 2nd St, Suite 215, Boise, ID 83702-6109 | |
| (208) 342-2706 | |
| Not Available |
| Full Name | James R Swartley |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 222 N 2nd St, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003861253 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | M3021 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James R Swartley, MD 222 N 2nd St, Suite 215, Boise, ID 83702-6109 Ph: (208) 342-2706 | James R Swartley, MD 222 N 2nd St, Suite 215, Boise, ID 83702-6109 Ph: (208) 342-2706 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that data from the second Phase III trial of microplasmin (TG-MV-007) for the non-surgical treatment of vitreomacular adhesion (VMA), are to be presented at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress.
Far from being a pitchfork-wielding populist who wants to raze Washington, Romney said he would work with the people he finds there. ... He bragged that in his old job as governor, he met with Democrats every week. He boasted about his bipartisan health care bill. ... he gave us a hint of a strong center-right pragmatic approach.
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.
Cognitive and motor decline may be slower in patients with early-onset Parkinson's disease if they have PARKIN mutations, suggests an analysis of the Consortium on Risk for Early-Onset PD study.
Results from a clinical trial of eteplirsen, a drug designed to treat Duchenne muscular dystrophy, suggest that the therapy allows participants to walk farther than people treated with placebo and dramatically increases production of a protein vital to muscle growth and health.
› Verified 1 days ago
Dr. Mark J Boerner, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 111 W Main St Ste 200, Boise, ID 83702 Phone: 208-344-3220 Fax: 208-344-0461 | |
Landon Kelly Grange, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 5680 W Gage St, Boise, ID 83706 Phone: 208-773-3937 Fax: 208-377-3937 | |
Dr. Chad Harman Jackson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 111 W Main St Ste 200, Boise, ID 83702 Phone: 208-344-3220 Fax: 208-344-0461 | |
Daniel R Brooks, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 222 N 2nd St, Ste 215, Boise, ID 83702 Phone: 208-381-6910 | |
John R Sonntag, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5680 W Gage St, Boise, ID 83706 Phone: 208-377-3937 Fax: 208-377-9455 | |
Ali Torab Parhiz, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 901 N Curtis Rd Ste 302, Boise, ID 83706 Phone: 812-424-2020 |